SHILPA MEDICARE Q2 FY27 |

• Net Profit: ₹79 Cr | ↑ 80% YoY | ↓ 22% QoQ

• Revenue: ₹529 Cr | ↑ 43% YoY | ↑ 14% QoQ

• Operating Profit: ₹142 Cr | ↑ 31% YoY

• Operating Margin: 26.9% vs 29.3% YoY (↓ 240 bps)

• EPS: ₹4.05 | ↑ 80% YoY | ↓ 22% QoQ

• Other Income: ₹9 Cr

TAMBOLI INDUSTRIES Q2 FY27 |

• Net Profit: ₹3 Cr | ↑ 76% YoY | ↑ 63% QoQ

• Revenue: ₹24 Cr | ↑ 23% YoY | ↑ 28% QoQ

• EBITDA: ₹6 Cr | ↑ 70% YoY | ↑ 51% QoQ

• EBITDA Margin: 24.1% vs 17.3% YoY | 20.3% QoQ

MAHINDRA & MAHINDRA Q2 FY27 RESULTS VS ESTIMATES

• Net Profit: ₹5,102 Cr vs ₹4,757 Cr Est. | Beat by 7.25%

• Revenue: ₹42,477 Cr vs ₹42,110 Cr Est. | Beat by 0.87%

• EBITDA: ₹4,912 Cr vs ₹4,905 Cr Est. | Beat by 0.14%

• EBITDA Margin: 11.6% vs 11.6% Est. | In line

M&M Auto and Tractor Internals

Stock up 5%

Mahindra & Mahindra Ltd – CHANGE IN MANAGEMENT

Board meeting outcome held on 5th November 2026:

- Ms. Shuchi Suri to transition to Chief Sales & Marketing Officer - Automotive Business

- Transition effective from 1st April 2027

- Ms. Shuchi Suri will cease to be Senior Management Personnel upon transition

- Board approved Unaudited Standalone and Consolidated Financial Results for Q2 and Half year ended 30th September 2026

LLOYDS ENTERPRISES Q2 FY27 (CONSOLIDATED) | OK 🌱

• Net Profit: ₹13.70 Cr | ↓ 41.60% YoY | ↓ 76.61% QoQ

• Revenue: ₹693.91 Cr | ↑ 70.67% YoY | ↑ 23.25% QoQ

• EBITDA: ₹50.22 Cr | ↑ 111.81% YoY | ↓ 43.15% QoQ

• EBITDA Margin: 7.24% vs 5.83% YoY | 15.69% QoQ

BHARAT FORGE Q2 FY27 – RESULTS VS ESTIMATES

• Net Profit: ₹278.6 Cr vs Est. ₹342 Cr – Miss by 18.54% 🔴

• Revenue: ₹4,870 Cr vs Est. ₹4,765 Cr – Beat by 2.20% 🟢

• EBITDA: ₹768 Cr vs Est. ₹794 Cr – Miss by 3.27% 🔴

• EBITDA Margin: 18.8% vs Est. 16.7% – Beat by 210 bps 🟢

Bharat Forge Ltd – Q2FY27 FINANCIAL RESULTS HIGHLIGHTS AND INVESTMENT UPDATE

Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026:

- Consolidated revenue from operations: INR 48,699.66 million for Q2

- Consolidated profit for the quarter: INR 2,786.81 million

- Consolidated revenue for half year ended Sep-2026: INR 95,099.07 million

- Approved investment in Kalyani Strategic Systems Limited (KSSL): up to INR 290.51 Cr

- Forgings segment revenue (Q2): INR 38,939.95 million

- Defence segment revenue (Q2): INR 4,727.25 million

SANDHAR TECHNOLOGIES Q2 FY27 | GOOD ✅

• Net Profit: ₹56 Cr | ↓ 24% YoY | ↑ 50% QoQ

• Revenue: ₹1,618 Cr | ↑ 27% YoY | ↑ 17% QoQ

• Operating Profit: ₹137 Cr | ↑ 16% YoY | ↑ 30% QoQ

• Operating Margin: 8.5% vs 9.3% YoY | 7.6% QoQ

• EPS: ₹9.31 | ↓ 24% YoY | ↑ 50% QoQ

• Other Income: ₹6 Cr

TUBE INVESTMENTS Q2 FY27 | GREAT 🌟

• Net Profit: ₹421 Cr | ↑ 39% YoY | ↑ 43% QoQ

• Revenue: ₹7,330 Cr | ↑ 33% YoY | ↑ 18% QoQ

• Operating Profit: ₹734 Cr | ↑ 35% YoY | ↑ 34% QoQ

• Operating Margin: 10.0% vs 9.9% YoY | 8.8% QoQ

• EPS: ₹12.87 | ↑ 33% YoY | ↑ 48% QoQ

• Other Income: ₹111 Cr

SURAT TRADE Q2 FY27 (STANDALONE) | OK 🌱

• Net Profit: ₹1.81 Cr | ↑ 572.99% YoY | ↓ 81.25% QoQ

• Revenue: ₹51.66 Cr | ↑ 209.90% YoY | ↑ 4.70% QoQ

• EBITDA: ₹1.33 Cr Loss | Loss narrowed YoY | Loss vs Profit QoQ

• EBITDA Margin: -2.58% vs -9.90% YoY | 6.71% QoQ

IGARASHI MOTORS Q2 FY27 (STANDALONE) | OK 🌱

• Net Profit: ₹6 Cr | ↑ 41% YoY | ↓ 6% QoQ

• Revenue: ₹255 Cr | ↑ 17% YoY | ↑ 2% QoQ

• Operating Profit: ₹26 Cr | ↑ 13% YoY | ↑ 8% QoQ

• Operating Margin: 10.4% vs 10.7% YoY | 9.8% QoQ

• EPS: ₹2.03 | ↑ 41% YoY | ↓ 6% QoQ

• Other Income: Nil

OIL COUNTRY TUBULAR Q2 FY27 (STANDALONE) | GOOD ✅

• Net Loss: ₹12 Cr | Loss narrowed 43% YoY | 18% QoQ

• Revenue: ₹25 Cr | ↑ 150% YoY | ↑ 44% QoQ

• EBITDA: ₹4 Cr Profit vs ₹2 Cr Loss (YoY) | ↑ 245% QoQ

• EBITDA Margin: 15.2% vs -23.0% YoY | 6.4% QoQ

BHARAT FORGE: H2 FY27 OUTLOOK CO SAYS MAINTAIN EXPECTATIONS OF REVENUE GROWTH OF 20-25% IN FY27 FOR THE INDIAN MANUFACTURING BUSINESS.

Strong Guidance from Shilpa Medi

CDMO orders from EU to contribute in H2

EU commercial supplies begin 2HFY27 for CDMO

Margins expansion due to better utilization

CDMO Biologic offerings to drive significant biosimilar revenue growth

📊 SJS ENTERPRISES Q2 FY27 – CONCALL HIGHLIGHTS

• Raises FY27 EBITDA margin guidance to 29–30%.

• Revises revenue growth guidance to 1.2–1.5x industry growth.

• Targets export contribution of 14–15% by FY28.

• Targets ₹500–700 Cr display revenue by 2031.

BMW INDUSTRIES Q2 FY27

• Net Profit: ₹22 Cr | ↑ 44% YoY | ↑ 13% QoQ

• Revenue: ₹182 Cr | ↑ 25% YoY | ↑ 9% QoQ

• Operating Profit: ₹35 Cr | ↓ 6% YoY | ↑ 3% QoQ

• Operating Margin: 19.2% vs 25.5% YoY | 20.3% QoQ

• EPS: ₹0.96 | ↑ 43% YoY | ↑ 13% QoQ

• Other Income: ₹14 Cr

IRB INFRASTRUCTURE Q2 FY27

• Net Profit: ₹260 Cr | ↑ 85% YoY | ↓ 15% QoQ

• Revenue: ₹1,897 Cr | ↑ 8% YoY | ↓ 11% QoQ

• Operating Profit: ₹1,055 Cr | ↑ 14% YoY | ↓ 8% QoQ

• Operating Margin: 55.6% vs 52.8% YoY | 53.9% QoQ

• EPS: ₹0.22 | ↑ 83% YoY | ↓ 12% QoQ

• Other Income: ₹47 Cr

IPCALAB: Q2 CONS NET PROFIT 3.75B RUPEES VS 2.83B (YOY)

IPCALAB: Q2 EBITDA 6.73B RUPEES VS 5.45B (YOY); Q2 EBITDA MARGIN 23.14% VS 21.32% (YOY)

IPCALAB: Q2 REVENUE 29.1B RUPEES VS 25.57B (YOY)

NIFTY UP 600 PTS